Showing 10,301 - 10,320 results of 11,314 for search '"eventing"', query time: 0.10s Refine Results
  1. 10301

    Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience by Cheng Guo, Jin Zhou, Guoli Wang, Jie Wu

    Published 2025-01-01
    “…Steroid-free clinical remission and adverse events were recorded. Results: In this retrospective study, out of 520 children with IBD, twelve children (2.3%) were diagnosed with refractory PIBD and met the criteria for dual biotherapy, including four with UC (33%) and eight with CD (67%). …”
    Get full text
    Article
  2. 10302

    Fully Covered Stent-TIPS for Advanced HCC Patients with Portal Vein Tumor Thrombus-Related Severe Symptomatic Portal Hypertension by Liu Z, Lyu T, Yang J, Xie Y, Fan S, Song L, Zou Y, Wang J

    Published 2025-01-01
    “…The evaluated outcomes included overall survival (OS), technical success rate, reduction in portal venous pressure gradient (PPG), stent patency rate, SPH control rate, liver function and complications.Results: The technical success rate was 100% without perioperative deaths or severe procedure-related adverse events. The average PPG decreased by 13.4± 4.6 mmHg. …”
    Get full text
    Article
  3. 10303

    Non-inferiority study to compare the efficacy of relugolix with dienogest for endometriosis-associated pain and usefulness of administering relugolix prior to dienogest (READY stud... by Fuminori Taniguchi, Motoko Fukui, Yutaka Osuga, Tasuku Harada, Jo Kitawaki

    Published 2025-02-01
    “…The safety outcomes will include treatment-emergent adverse events, bone density, bone markers, menstrual status, genital bleeding, and endometrial thickness. …”
    Get full text
    Article
  4. 10304

    Association of frailty with non-laboratory based cardiovascular disease risk score among older adults and elderly population: insights from longitudinal aging study in India (LASI-... by Pritam Halder, Semanti Das, Anshul Mamgai, Divya Sharma, Ashish Behera, Pulak Syal, Vineeth Rajagopal, Tanvi Kiran

    Published 2025-01-01
    “…The WHO non-laboratory-based CVD risk scores are reliable predictors of cardiovascular events and are used in treatment decision-making in primary health-care settings. …”
    Get full text
    Article
  5. 10305

    Effectiveness and Safety of Four Aerobic Exercise Intensity Prescription Techniques in Rehabilitation Training for Patients with Coronary Heart Disease by Tao Chen, Huiying Zhu, Qingyuan Su

    Published 2022-01-01
    “…None of the participants had serious adverse events. There were no risks of ECG abnormalities in the low- and moderate-risk groups. …”
    Get full text
    Article
  6. 10306

    The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma by Wu Y, Zhu J, Zhang H, Xia N

    Published 2025-02-01
    “…Group A also exhibited significantly higher rates of overall adverse events including hypertension, abdominal pain, leukopenia, thrombocytopenia, and hypoproteinemia as compared to Group B, although the incidence of hand-foot syndrome in Group A was significantly reduced as compared to Group B (13.3% vs 42.8%). …”
    Get full text
    Article
  7. 10307

    Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma by Ziting Peng, Jianhui Dong, Shuyao Tang, Jiaxu Shi, Tongdong Shi

    Published 2025-02-01
    “…However, no significant disparity in the PFS with immunotherapy in different lines therapy(P=0.406) and the OS was observed between the two groups(P=0.360). 18 patients (18.75%) experienced treatment-emergent adverse events (AEs), with 3 patients encountering AEs of grade ≥3. …”
    Get full text
    Article
  8. 10308

    A Multidisciplinary-Based and Bundle Intervention for Controlling Carbapenem-Resistant Organisms in Neurosurgery by Zhu W, Liang Y, Xu J, Weng C

    Published 2025-02-01
    “…The surveillance analysis and event analysis were used to identify the key links and targeted pathogens of the intervention. …”
    Get full text
    Article
  9. 10309

    Preclinical evaluation and preliminary clinical study of 68Ga-NODAGA-NM-01 for PET imaging of PD-L1 expression by Lingzhou Zhao, Jiali Gong, Sisi Liao, Wenhua Huang, Jinhua Zhao, Yan Xing

    Published 2025-01-01
    “…Furthermore, 68Ga-NODAGA-NM-01 PET/CT imaging was found to be safe with no adverse events and distinct uptake in primary and metastatic lesions of the PD-L1-positive patient, with a higher maximal standardized uptake value than that in lesions of the PD-L1-negative patient 1h post-injection. …”
    Get full text
    Article
  10. 10310

    Implementasi Kurikulum 2013 Revisi 2016 Pada Pembelajaran Menulis Teks Anekdot by Rasyid Manshur, Sarwiji Suwandi, Suyitno Suyitno

    Published 2018-12-01
    “…The data sources in this research were events (the process of writing anecdote text), informants (teachers and students), and documents (the syllabus and lesson plan). …”
    Get full text
    Article
  11. 10311

    Comparison of Hydrus and iStent microinvasive glaucoma surgery implants in combination with phacoemulsification for treatment of open-angle glaucoma: systematic review and network... by Xiaoyu Wang, Rongrong Hu, Dongyu Guo, Nan Hong, Xiuyuan Xuan

    Published 2022-06-01
    “…Safety was estimated using the proportions of adverse events. The network meta-analysis was conducted within a Bayesian framework using the Markov Chain Monte Carlo method in ADDIS software.Results Six prospective RCTs comprising 1397 patients were identified. …”
    Get full text
    Article
  12. 10312

    Hubungan Faktor Risiko yang dapat Dimodifikasi dengan Kejadian Penyakit Jantung Koroner di RS Dr. M. Djamil Padang by Suchi Ilmi Herman, Muhammad Syukri, Efrida .

    Published 2015-05-01
    “…The objective of this study was to determine the relationship of modifiable risk factors with CHD events. This study was a cross-sectional analytic design conducted at Hospital Dr. …”
    Get full text
    Article
  13. 10313

    Scalar Field Kantowski–Sachs Solutions in Teleparallel <i>F</i>(<i>T</i>) Gravity by Alexandre Landry

    Published 2025-01-01
    “…Some new <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>F</mi><mo>(</mo><mi>T</mi><mo>)</mo></mrow></semantics></math></inline-formula> solution classes may be relevant for future cosmological applications, especially concerning dark matter, dark energy quintessence, phantom energy leading to the Big Rip event, and quintom models of physical processes.…”
    Get full text
    Article
  14. 10314

    Efficacy and Safety of Ergoferon in Children from 6 Months to 6 Years Old with Acute Respiratory Viral Infections in Contemporary Outpatient Practice: A Multicenter, Double-Blind,... by N. A. Geppe, B. M. Blokhin, O. V. Shamsheva, S. T. Abdrakhmanova, K. A. Alikhanova, G. T. Myrzabekova

    Published 2021-01-01
    “…The incidence of adverse events (AEs) in the Ergoferon group was significantly lower compared to the placebo group (7.0% versus 18.8%; p=0.004) including infectious diseases (3.5% vs 12.5%; p=0.008). …”
    Get full text
    Article
  15. 10315

    Sarcomatous tumor with external iliac vein aneurysm: a rare entity by Tushar Kalekar, Neeha Amit Jhala, Reetika Kapoor, Eshan Chetan Durgi, Karishma Krishnani

    Published 2025-01-01
    “…While these aneurysms can be primary or secondary in nature, secondary cases predominate and require prompt medical attention due to risks of rupture and thromboembolic events. This case report describes an unusual presentation of thigh soft tissue sarcoma complicated by external iliac venous aneurysm formation, highlighting the importance of early recognition and management of vascular complications in sarcoma patients. …”
    Get full text
    Article
  16. 10316

    Identifying [between] Geser and Genghis Khan. Part 1: Contamination of Images in Folklore and Historical Memories of Central and Inner Asia by Natalia N. Nikolaeva, Evgenii V. Nolev

    Published 2024-09-01
    “…The involvedness of Siberia’s peoples ― including Buryat clans and tribes (despite their largely peripheral locations) ― in general Mongolian historical events led to the two characters became equally popular, widespread, and somewhat sacral folklore images. …”
    Get full text
    Article
  17. 10317

    Our experience of buffalo improvement in India: last 50 years journey by T. K. Datta

    Published 2023-11-01
    “…India’s story as the largest producer of milk is eventful. There was a phase when the country’s milk production hit an all-time low, a mere 17 million Tonnes (mT) in 1950. …”
    Get full text
    Article
  18. 10318

    Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study by Jennifer Moore, Alicia Aylott, Wen-Hung Chen, Jerzy Daniluk, Ian A. Hawes, Sergio Parra, Prosenjit Sarkar, Yasmin Sanchez-Pearson, Megan Turner, Amanda Peppercorn, Andrew Skingsley

    Published 2025-12-01
    “…Incidence of adverse events (AEs), serious AEs (SAEs) and AEs of special interest (AESIs) were assessed, along with patient-reported outcomes (Perception of Injection version 3 questionnaire and Pain-Numeric Rating Scale [Pain-NRS]). …”
    Get full text
    Article
  19. 10319

    Remote symptom monitoring with patient-reported outcomes and nudges during lung cancer immunotherapy in China (PRO-NET): protocol for a randomised controlled trial by Ping He, Yanan Luo, Zhenyu Shi, Yiqi Xia, Xiaolong Guan

    Published 2025-01-01
    “…For advanced NSCLC, immunotherapy offers substantial survival benefits but is often accompanied by severe immune-related adverse events symptoms, significantly affecting health-related quality of life (HRQoL). …”
    Get full text
    Article
  20. 10320

    The safety and efficacy of immune checkpoint blockade in children, adolescents, and young adults: A systematic review and meta-analysis by Pedro C.A. Reis, João Evangelista Ponte Conrado, Mariana Macambira Noronha, Luís Felipe Leite da Silva, Erick Figueiredo Saldanha, Jonathan Metts

    Published 2025-06-01
    “…We pooled the incidences of treatment-related adverse events (TRAEs), objective response rates (ORRs), stable disease (SD), and their corresponding confidence intervals (CIs). …”
    Get full text
    Article